Watchlist Price Alert

Revolution Medicines Inc. (RVMD)

NASDAQ: RVMD · Real-Time Price · USD

39.98

0.21 (0.53%)

At close: Jun 17, 2025, 10:51 AM

Revolution Medicines Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	543.06M	696.15M	161.41M	108.5M	104.27M	16.66M	69.59M	9.08M
Short-Term Investments	1.75B	1.16B	483.53M	468.56M	336.47M	106.1M	n/a	n/a
Long-Term Investments	n/a	n/a	1.74M	1.74M	1.08M	214K	214K	n/a
Other Long-Term Assets	17.57M	10.06M	-23.4M	-14.49M	-19.13M	-8.27M	-2.54M	383K
Receivables	n/a	1.25M	4.67M	5.93M	6.39M	8.74M	7.3M	n/a
Inventory	n/a	n/a	n/a	-12.72M	n/a	n/a	6.6M	n/a
Other Current Assets	38.33M	25.07M	10.57M	n/a	n/a	n/a	6.91M	n/a
Total Current Assets	2.33B	1.88B	660.18M	577.05M	454.12M	133.98M	85.43M	9.44M
Property-Plant & Equipment	141.82M	100.01M	73.74M	71.24M	36.34M	7.15M	6.87M	5.25M
Goodwill & Intangibles	71.28M	72.35M	73.42M	74.48M	75.55M	76.62M	77.69M	n/a
Total Long-Term Assets	230.67M	182.42M	151.75M	160.93M	113.28M	86.55M	85.16M	5.64M
Total Assets	2.56B	2.06B	811.93M	737.99M	567.4M	220.53M	170.59M	15.08M
Account Payables	54.43M	61.79M	21.31M	14.06M	12.61M	11.4M	5.24M	3.35M
Deferred Revenue	n/a	n/a	4.46M	18.93M	20.59M	17.12M	16.83M	n/a
Short-Term Debt	12.87M	n/a	6.77M	6.21M	n/a	n/a	n/a	n/a
Other Current Liabilities	78.71M	51.08M	9.39M	11.65M	7.83M	5.53M	3.48M	2.78M
Total Current Liabilities	163.91M	143.85M	61.98M	18.93M	47.18M	43.05M	30.55M	7.6M
Long-Term Debt	122.97M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	3.86M	7.97M	301K	634K	632K	2.4M	2.77M	2.95M
Total Long-Term Liabilities	129.18M	91.66M	64.76M	116.49M	45.55M	24.94M	43.38M	2.95M
Total Liabilities	293.1M	235.51M	126.74M	135.42M	92.72M	67.99M	73.93M	10.55M
Total Debt	135.84M	87.94M	64.2M	66.63M	32.66M	172K	147K	n/a
Common Stock	18K	16K	9K	8K	7K	n/a	3K	1K
Retained Earnings	-1.74B	-1.14B	-701.34M	-452.64M	-265.55M	-157.39M	-109.72M	-67.93M
Comprehensive Income	1.32M	544K	-1.78M	-376K	116K	74K	-3.62M	-2.18M
Shareholders Equity	2.27B	1.83B	685.19M	602.57M	474.68M	152.53M	96.66M	4.53M
Total Investments	1.75B	1.16B	483.53M	468.56M	336.47M	106.1M	214K	n/a